相关实验视频
Updated: Jul 1, 2025

06:27
Transcutaneous Microcirculatory Imaging in Preterm Neonates
Published on: December 31, 2015
8.2K
一个极端早产婴儿的数字缺血治疗用酸甘油贴片治疗的婴儿
Mansour Al Qurashi1,2, Abdulaziz Al-Khotani3,4, Farzeen Mohtisham1,2
1Department of Pediatrics, Ministry of National Guard Health Affairs (MNGHA), King Saud Bin Abdul Aziz University for Health Sciences (KSAU-HS), WR King Abdulaziz Medical City, Jeddah, Saudi Arabia.
Case reports in pediatrics
|March 7, 2024
概括
新生儿缺血四肢病变可能发生在重症监护室. 局部用酸甘在治疗早产婴儿的数字性缺血方面表现有前途,正如最近的一项案例研究所示.
科学领域:
- 新生儿科学 新生儿科学
- 儿科血管医学 儿科血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 缺血性四肢病变是新生儿重症监护病房中已知的并发症.
- 危险因素包括动脉导管,血液采样和血管活性药物.
- 在极端早产婴儿的外周组织缺血的管理缺乏标准化的方法.
相关概念视频
Antianginal Drugs: Nitrates and β-Blockers
586
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
586
Antihypertensive Drugs: Vasodilators
519
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
519
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
181
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
181

